PO-1422 Hypofractionated salvage radiotherapy in patients with biochemical recurrence of prostate cancer. (May 2022) - Matrone, F.; Fanetti, G.; Revelant, A.; Polesel, J.; Chiovati, P.; Franchin, G.; Bortolus, R.